Related Experiment Video
Updated: Feb 14, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
An Epigenetic Switch: From Senescent Melanocytes to Malignant Melanoma (and Back)
1MRC London Institute of Medical Sciences (LMS), Du Cane Road, London W12 0NN, UK; Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK.
Abstract:
Oncogene-induced senescence is an important barrier during melanomagenesis. In this issue of Cancer Cell, Yu et al. show how elevated expression of structurally unrelated H3K9 demethylases disables senescence and constitutes a liability that can be exploited to restore senescence in melanoma by pharmacological inhibition of these epigenetic regulators.
Insights
Melanoma cells evade senescence through increased H3K9 demethylase expression. Targeting these epigenetic regulators can restore senescence, offering a new therapeutic strategy for melanoma treatment.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Oncogene-induced senescence acts as a crucial tumor suppressor mechanism in melanoma development.
- Dysregulation of senescence pathways contributes to melanoma progression.
Purpose of the Study:
- To investigate the role of H3K9 demethylases in overcoming oncogene-induced senescence during melanomagenesis.
- To explore the potential of targeting epigenetic regulators for restoring senescence in melanoma.
Main Methods:
- Analysis of H3K9 demethylase expression in melanoma.
- Investigating the functional impact of H3K9 demethylases on senescence pathways.
- Evaluating pharmacological inhibition of H3K9 demethylases to restore senescence.
Main Results:
- Elevated expression of structurally unrelated H3K9 demethylases was found to disable senescence.
- These epigenetic regulators represent a vulnerability that can be targeted in melanoma.
- Pharmacological inhibition successfully restored senescence in melanoma models.
Conclusions:
- Aberrant H3K9 demethylase activity is a key mechanism enabling melanoma cells to evade senescence.
- Targeting H3K9 demethylases offers a promising epigenetic therapy strategy for melanoma.
More Related Videos
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Switching of BJT
Cut-off Mode ("Off" State): In this state, both the emitter-base and collector-base junctions are...
Replicative Cell Senescence
Telomeres and Telomerase
Reproductive Cloning
Somatic Cell Nuclear Transfer
In SCNT, an egg cell is taken from an animal and its nucleus is removed, creating an enucleated egg. Then a somatic...

